Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviSelf-StudyManagement of Cirrhosis-Related Complications
Management of Cirrhosis-Related Complications
Sign In or Register to get started
Management of Cirrhosis-Related Complications
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 3 Overview
Screening for Varices and Prevention of Bleeding - 0%Topic 1
Pathophysiology and Portal DynamicsActivities- 0%Topic 2
Diagnosing Clinically Significant Portal Hypertension and Predicting VaricesActivities- 0%Topic 3
Management of Compensated Cirrhosis with Clinically Significant Portal HypertensionActivities- 0%Topic 4
Prophylaxis of Variceal BleedingActivities- 0%Topic 5
Treatment of Acute Variceal BleedingScreening for Varices and Prevention of Bleeding Overview
About this Lesson
Last Updated: February 27th, 2024CNE/CME Continuing Education
This lesson qualifies for:- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour and 1 CE contact hour (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: August 29th, 2013CNE and CME Review: March 15th, 2024CNE and CME Expiration: March 14th, 2027 (4th Edition)
View CE NoticesSteps to Acquire CE for this Lesson:
1Quiz
Score 80%+2Give Feedback
Complete survey3Print CE Certificate
Obtain proof of CE4th Edition
This is a substantial revision of the original Lesson. The previous edition was titled Screening for Varices and Prevention of Bleeding and available until March 15th, 2024.Learning Objectives
- Explain the basic pathogenesis of cirrhosis-related portal hypertension
- Describe how to diagnose clinically-significant portal hypertension
- Discuss the rationale and indications for variceal screening in persons with cirrhosis
- Summarize recommendations for prophylaxis of variceal bleeding
- List key aspects of managing acute variceal bleeding
Lesson Contributors
Authors
Jennifer Price, MD, PhDJennifer Price, MD, PhD
Professor of Medicine
Director, UCSF Viral Hepatitis Center
Division of GI and Hepatology
University of California, San FranciscoDisclosures:- Grants, Research support to Institution: Abbvie, Genentech, Vir Biotechnology, Zydus Pharmaceuticals
The relevant financial relationship was mitigated.Reviewers
H. Nina Kim, MD, MScH. Nina Kim, MD, MSc
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneDavid H. Spach, MDDavid H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneLesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
Funded byCenters for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)Created at University of WashingtonPart of IDEA PlatformCME provided byUniversity of Alabama BirminghamCNE provided byUniversity of Washington School of NursingCopyright © 2024 Hepatitis C OnlineSince you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-master-c8843673-2024-11-13-205624 - 0%Topic 2